| 摘要 |
<p>The present invention relates to a composition for the removal of at least one undesired electrolyte and/or metabolite in a patient, which comprises a genetically engineered E. coli DH5 cells microencapsulated in artificial cells to be capable of removing said undesired electrolyte and/or metabolite, wherein said undesired electrolyte is selected from the group consisting of K, Mg, P, Na, Cl and said undesired metabolite is selected from the group consisting of uric acid, cholesterol, bilirubin, and creatinine, wherein said removal of undesired electrolyte and/or metabolite lowers the undesired chemical concentration to a therapeutically acceptable level.</p> |
